CAS 636-54-4
:Clopamide
- 4-Chloro-N-(cis-2,6-dimethylpiperidino)-3-sulfamoylbenzamide
- 4-chloro-N-(2,6-dimethylpiperidin-1-yl)-3-sulfamoylbenzamide
- 4-chloro-N-(2,6-dimethylpiperidino)-3-sulphamoylbenzamide
- 4-chloro-N-[(2R,6S)-2,6-dimethylpiperidin-1-yl]-3-sulfamoylbenzamide
- Adurix
- Aquex
- Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,6-dimethyl-1-piperidinyl)-, cis-
- Benzamide, 3-(aminosulfonyl)-4-chloro-N-[(2R,6S)-2,6-dimethyl-1-piperidinyl]-, rel-
- Benzamide, 4-chloro-N-(2,6-dimethylpiperidino)-3-sulfamoyl-, cis-
- Brinaldix
- Chlosudimeprimyl
- Clopamidum
- Dt 327
- N-(cis-2′,6′-Dimethyl-1′-piperidyl)-3-sulfamyl-4-chlorobenzamide
- Voir plus de synonymes
CLOPAMIDE FOR SYSTEM SUITABILITY CRS
CAS :CLOPAMIDE FOR SYSTEM SUITABILITY CRSFormule :C14H20ClN3O3SCouleur et forme :Crystalline Powder. White. Whitish. Powder., Crystalline Powder. White. Whitish. Powder.Masse moléculaire :345.8449CLOPAMIDE CRS
CAS :CLOPAMIDE CRSFormule :C14H20ClN3O3SCouleur et forme :Crystalline Powder. White. Whitish. Powder., Crystalline Powder. White. Whitish. Powder.Masse moléculaire :345.8449Benzamide,3-(aminosulfonyl)-4-chloro-N-[(2R,6S)-2,6-dimethyl-1-piperidinyl]-, rel-
CAS :Formule :C14H20ClN3O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :345.8449Clopamide
CAS :Formule :C14H20ClN3O3SDegré de pureté :≥ 98.0%Couleur et forme :White to off-white powderMasse moléculaire :345.84Clopamide
CAS :Produit contrôléApplications Antihypertensive; diuretic.
References McNeil, J.J., et al.: Clin. Pharmacol. Ther., 42, 299 (1987), Crowder, D., et al.: Curr. Med. Res. Opin., 6, 342 (1979),Formule :C14H20ClN3O3SCouleur et forme :Light YellowMasse moléculaire :345.84Clopamide
CAS :Clopamide (Brinaldix) is a piperidine and sulfamoylbenzamide-based diuretic with thiazide-like diuretic activity.Formule :C14H20ClN3O3SDegré de pureté :99.71%Couleur et forme :White To Yellowish Crystalline PowderMasse moléculaire :345.84Clopamide
CAS :Clopamide is a diuretic drug that belongs to the group of protein genes. It is used in the treatment of chronic heart failure, low-density lipoprotein cholesterol and infectious diseases. Clopamide has been shown to increase the glomerular filtration rate by inhibiting the sodium citrate enzyme, which is involved in the formation of urine from blood plasma. This drug also reduces blood pressure by blocking angiotensin II receptors on vascular smooth muscle cells. Clopamide does not have any significant interactions with other drugs, although caution should be exercised when using it with cardiac drugs due to its effects on blood pressure.
Formule :C14H20ClN3O3SDegré de pureté :Min. 98 Area-%Couleur et forme :White PowderMasse moléculaire :345.85 g/mol








